Herbert Loong, Advisor at Greater Bay Area International Clinical Trial Institute, and Steering Committee Member at Lung Cancer Policy Network, shared a post on LinkedIn:
“Delighted to be in Jinan to attend my first ever Chinese Society of Clinical Oncology CSCO26 meeting.
Over 30k attendees in this 3 days event, with a handful of us from hongkong.
Had the pleasure of opening the sarcoma session discussing about evolving management of desmoid tumours.”
Other articles about Chinese Society of Clinical Oncology on OncoDaily.
